1887

Abstract

Introduction:

Globally, extra-intestinal pathogenic Escherichia coli are one of the predominant causative agents of bacteraemia.

Case presentation:

This case report outlines a presentation of community-acquired pyelonephritis and secondary bloodstream infection in an 81-year-old man. Laboratory investigations revealed that the causative isolate was a multi-drug-resistant E. coli of a novel multi-locus sequence type. This sequence type (ST) was designated ST-458 and was most closely related to the globally prevalent ST-131 lineage.

Conclusion:

This is the first report of a novel E. coli ST, ST-458, which caused pyelonephritis and bacteraemia.

Loading

Article metrics loading...

/content/journal/jmmcr/10.1099/jmmcr.0.005061
2016-10-01
2019-10-21
Loading full text...

Full text loading...

/deliver/fulltext/jmmcr/3/5/jmmcr005061.html?itemId=/content/journal/jmmcr/10.1099/jmmcr.0.005061&mimeType=html&fmt=ahah

References

  1. Al-Hasan M. N., Lahr B. D., Eckel-Passow J. E., Baddour L. M..( 2009;). Antimicrobial resistance trends of Escherichia coli bloodstream isolates: a population-based study, 1998-2007. . J Antimicrob Chemother 64: 169–174.[CrossRef]
    [Google Scholar]
  2. Alhashash F., Weston V., Diggle M., McNally A..( 2013;). Multidrug-resistant Escherichia coli bacteremia. . Emerg Infect Dis 19: 1699–1701. [CrossRef] [PubMed]
    [Google Scholar]
  3. de Kraker M. E., Jarlier V., Monen J. C., Heuer O. E., van de Sande N., Grundmann H..( 2013;). The changing epidemiology of bacteraemias in Europe: trends from the European Antimicrobial Resistance Surveillance System. . Clin Microbiol Infect 19: 860–868. [CrossRef] [PubMed]
    [Google Scholar]
  4. Guyer D. M., Radulovic S., Jones F. E., Mobley H. L..( 2002;). Sat, the secreted autotransporter toxin of uropathogenic Escherichia coli, is a vacuolating cytotoxin for bladder and kidney epithelial cells. . Infect Immun 70: 4539–4546. [CrossRef] [PubMed]
    [Google Scholar]
  5. Jackson L. A., Benson P., Neuzil K. M., Grandjean M., Marino J. L..( 2005;). Burden of community-onset Escherichia coli bacteremia in seniors. . J Infect Dis 191: 1523–1529. [CrossRef] [PubMed]
    [Google Scholar]
  6. Johnson J. R..( 1991;). Virulence factors in Escherichia coli urinary tract infection. . Clin Microbiol Rev 4: 80–128. [CrossRef] [PubMed]
    [Google Scholar]
  7. Lloyd A. L., Rasko D. A., Mobley H. L..( 2007;). Defining genomic islands and uropathogen-specific genes in uropathogenic Escherichia coli. . J Bacteriol 189: 3532–3546. [CrossRef] [PubMed]
    [Google Scholar]
  8. Miajlovic H., Smith S. G..( 2014;). Bacterial self-defence: how Escherichia coli evades serum killing. . FEMS Microbiol Lett 354: 1–9. [CrossRef] [PubMed]
    [Google Scholar]
  9. Miajlovic H., Cooke N. M., Moran G. P., Rogers T. R., Smith S. G..( 2014;). Response of extraintestinal pathogenic Escherichia coli to human serum reveals a protective role for Rcs-regulated exopolysaccharide colanic acid. . Infect Immun 82: 298–305. [CrossRef] [PubMed]
    [Google Scholar]
  10. Miajlovic H., Aogáin M. M., Collins C. J., Rogers T. R., Smith S. G..( 2016;). Characterization of Escherichia coli bloodstream isolates associated with mortality. . J Med Microbiol 65: 71–79. [CrossRef] [PubMed]
    [Google Scholar]
  11. Mulvey M. A., Schilling J. D., Martinez J. J., Hultgren S. J..( 2000;). Bad bugs and beleaguered bladders: interplay between uropathogenic Escherichia coli and innate host defenses. . Proc Natl Acad Sci U S A 97: 8829–8835. [CrossRef] [PubMed]
    [Google Scholar]
  12. Nicolas-Chanoine M. H., Bertrand X., Madec J. Y..( 2014;). Escherichia coli ST131, an intriguing clonal group. . Clin Microbiol Rev 27: 543–574. [CrossRef] [PubMed]
    [Google Scholar]
  13. Nipič D., Podlesek Z., Budič M., Črnigoj M., Žgur-Bertok D..( 2013;). Escherichia coli uropathogenic-specific protein, Usp, is a bacteriocin-like genotoxin. . J Infect Dis 208: 1545–1552. [CrossRef] [PubMed]
    [Google Scholar]
  14. Smith S. N., Hagan E. C., Lane M. C., Mobley H. L..( 2010;). Dissemination and systemic colonization of uropathogenic Escherichia coli in a murine model of bacteremia. . MBio 1: e0026210. [CrossRef] [PubMed]
    [Google Scholar]
  15. Stoesser N., Sheppard A. E., Pankhurst L., De Maio N., Moore C. E., Sebra R., Turner P., Anson L. W., Kasarskis A. et al.( 2016;). Evolutionary history of the global emergence of the Escherichia coli epidemic clone ST131. . MBio 7: e02162. [CrossRef] [PubMed]
    [Google Scholar]
  16. Subashchandrabose S., Smith S. N., Spurbeck R. R., Kole M. M., Mobley H. L..( 2013;). Genome-wide detection of fitness genes in uropathogenic Escherichia coli during systemic infection. . PLoS Pathog 9: e1003788. [CrossRef] [PubMed]
    [Google Scholar]
  17. Ulett G. C., Valle J., Beloin C., Sherlock O., Ghigo J. M., Schembri M. A..( 2007;). Functional analysis of antigen 43 in uropathogenic Escherichia coli reveals a role in long-term persistence in the urinary tract. . Infect Immun 75: 3233–3244. [CrossRef] [PubMed]
    [Google Scholar]
  18. Walsh P., Carroll J., Sleator R. D..( 2013;). Accelerating in silico research with workflows: a lesson in Simplicity. . Comput Biol Med 43: 2028–2035. [CrossRef] [PubMed]
    [Google Scholar]
  19. Weissman S. J., Johnson J. R., Tchesnokova V., Billig M., Dykhuizen D., Riddell K., Rogers P., Qin X., Butler-Wu S. et al.( 2012;). High-resolution two-locus clonal typing of extraintestinal pathogenic Escherichia coli. . Appl Environ Microbiol 78: 1353–1360. [CrossRef] [PubMed]
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jmmcr/10.1099/jmmcr.0.005061
Loading
/content/journal/jmmcr/10.1099/jmmcr.0.005061
Loading

Data & Media loading...

Most Cited This Month

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error